A case series of NSCLC patients with different molecular characteristics and choroidal metastases: improvement in vision with treatment including pemetrexed and bevacizumab

J Thorac Oncol. 2013 Feb;8(2):e17-8. doi: 10.1097/JTO.0b013e31827690da.
No abstract available

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adenocarcinoma / pathology
  • Adenocarcinoma / therapy
  • Adult
  • Antibodies, Monoclonal, Humanized / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Bevacizumab
  • Bone Neoplasms / secondary
  • Bone Neoplasms / therapy
  • Carcinoma, Non-Small-Cell Lung / pathology
  • Carcinoma, Non-Small-Cell Lung / therapy*
  • Chemoradiotherapy*
  • Choroid Neoplasms / secondary
  • Choroid Neoplasms / therapy*
  • Cisplatin / administration & dosage
  • Glutamates / administration & dosage
  • Guanine / administration & dosage
  • Guanine / analogs & derivatives
  • Humans
  • Liver Neoplasms / secondary
  • Liver Neoplasms / therapy
  • Lung Neoplasms / pathology
  • Lung Neoplasms / therapy*
  • Male
  • Middle Aged
  • Pemetrexed
  • Prognosis
  • Vision Disorders / prevention & control*

Substances

  • Antibodies, Monoclonal, Humanized
  • Glutamates
  • Pemetrexed
  • Bevacizumab
  • Guanine
  • Cisplatin